CA2908028C - Methods and kits for the diagnosis of influenza - Google Patents

Methods and kits for the diagnosis of influenza Download PDF

Info

Publication number
CA2908028C
CA2908028C CA2908028A CA2908028A CA2908028C CA 2908028 C CA2908028 C CA 2908028C CA 2908028 A CA2908028 A CA 2908028A CA 2908028 A CA2908028 A CA 2908028A CA 2908028 C CA2908028 C CA 2908028C
Authority
CA
Canada
Prior art keywords
neuraminidase
sample
test
assay
immunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2908028A
Other languages
English (en)
French (fr)
Other versions
CA2908028A1 (en
Inventor
Robert Campbell
Kevin G. Dolan
Eric FALLOWS
Randal A. Hoke
Ross Jacobson
J. Bruce Pitner
Glenn Vonk
Rajashaker Kache
Upma GULATI
Herman HIMEL
Rosemary B. Evans-Storms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of CA2908028A1 publication Critical patent/CA2908028A1/en
Application granted granted Critical
Publication of CA2908028C publication Critical patent/CA2908028C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
CA2908028A 2013-04-01 2014-04-01 Methods and kits for the diagnosis of influenza Active CA2908028C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361807185P 2013-04-01 2013-04-01
US61/807,185 2013-04-01
PCT/US2014/032567 WO2014165536A1 (en) 2013-04-01 2014-04-01 Methods and kits for the diagnosis of influenza

Publications (2)

Publication Number Publication Date
CA2908028A1 CA2908028A1 (en) 2014-10-09
CA2908028C true CA2908028C (en) 2022-10-18

Family

ID=50625220

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2908028A Active CA2908028C (en) 2013-04-01 2014-04-01 Methods and kits for the diagnosis of influenza

Country Status (11)

Country Link
US (3) US10317404B2 (https=)
EP (1) EP2981618B1 (https=)
JP (2) JP6591398B2 (https=)
KR (1) KR102348484B1 (https=)
CN (2) CN105264086B (https=)
AU (2) AU2014248225B2 (https=)
BR (1) BR112015025042B1 (https=)
CA (1) CA2908028C (https=)
ES (1) ES2754402T3 (https=)
RU (1) RU2713112C2 (https=)
WO (1) WO2014165536A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6411740B2 (ja) * 2013-01-15 2018-10-24 国立大学法人広島大学 ノイラミニダーゼ活性阻害剤の有効性を判定するための組成物、キットおよびその利用
WO2014165536A1 (en) 2013-04-01 2014-10-09 Becton, Dickinson And Company Methods and kits for the diagnosis of influenza
US10520498B2 (en) 2017-03-14 2019-12-31 Becton, Dickinson And Company Devices and techniques for oral fluid collection and seroprotection testing
BR112019027993A2 (pt) * 2017-07-04 2020-07-07 Cavidi Ab métodos para avaliar a susceptibilidade de um vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, para avaliar se um paciente tratado para uma infecção viral tem necessidade de alterar a terapia farmacológica com um fármaco inibidor da enzima viral e para determinar a carga de um vírus em uma amostra do paciente e a dita resistência do vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, e, sistema
US11391748B2 (en) * 2017-09-21 2022-07-19 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing
JP7206257B2 (ja) 2017-09-21 2023-01-17 ベクトン・ディキンソン・アンド・カンパニー 危険汚染物質の収集キット及び迅速試験
CA3075769A1 (en) * 2017-09-21 2019-03-28 Becton, Dickinson And Company Sampling systems and techniques to collect hazardous contaminants with high pickup and shedding efficiencies
US11002642B2 (en) 2017-09-21 2021-05-11 Becton, Dickinson And Company Demarcation template for hazardous contaminant testing
WO2019060269A1 (en) * 2017-09-21 2019-03-28 Becton, Dickinson And Company KIT FOR COLLECTING HAZARDOUS CONTAMINANTS AND RAPID ANALYSIS
EP3684512B1 (en) 2017-09-21 2025-07-23 Becton, Dickinson and Company Augmented reality devices for hazardous contaminant testing
EP3685139B1 (en) 2017-09-21 2023-12-13 Becton, Dickinson and Company Reactive demarcation template and method for hazardous contaminant testing
US11324219B2 (en) * 2018-03-02 2022-05-10 Nihon Nohyaku Co., Ltd. Amide compound or salt thereof, agricultural and horticultural microbicide comprising the compound and the salt, and method for using the agricultural and horticultural microbicide
KR102129937B1 (ko) 2018-07-31 2020-07-03 재단법인 아산사회복지재단 종이기반 핵산검출용 키트 및 pcr 증폭산물을 분석하기 위한 방법
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CA3125355A1 (en) 2019-01-28 2020-08-06 Becton, Dickinson And Company Hazardous contaminant collection device with integrated swab and test device
CN113614534A (zh) * 2019-03-25 2021-11-05 积水医疗株式会社 呼吸道病毒的免疫测定方法和检测试剂盒
KR20230048505A (ko) * 2020-06-15 2023-04-11 뉴옴 펩타이즈 피티이. 엘티디. 분석물의 검출을 위한 측면 유동 검정 장치 및 이의 검출 방법
JP2022018768A (ja) * 2020-07-16 2022-01-27 デンカ株式会社 簡易鼻腔粘膜表面付着粘液の採取方法および該検体中の被検出物を検出するための検査キット
KR20220060269A (ko) 2020-11-04 2022-05-11 인텔로스 주식회사 코로나 바이러스 감염증 및 인플루엔자 바이러스 감염증 동시 진단키트
KR102265441B1 (ko) * 2020-12-23 2021-06-15 충남대학교 산학협력단 화학 발광 기반의 조류 인플루엔자 바이러스 검출용 조성물 및 이의 용도
CN115015541A (zh) 2021-03-05 2022-09-06 全球诊断系统受益有限责任公司 带流体贮存器的诊断装置及相关方法和试剂盒
JP2023016530A (ja) * 2021-07-21 2023-02-02 東洋紡株式会社 イムノクロマト試験片
JP2023016529A (ja) * 2021-07-21 2023-02-02 東洋紡株式会社 イムノクロマト試験片
US20250066867A1 (en) * 2023-08-23 2025-02-27 Vedabio, Inc. Rapid detection of known and emerging influenza viruses

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590169A (en) 1983-11-18 1986-05-20 Beckman Instruments, Inc. Direct particle agglutination immunoassays avoiding false negatives at high antigen concentrations
US4810631A (en) 1986-05-12 1989-03-07 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of chemical catalysis
US4835099A (en) 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis
US4904583A (en) 1987-05-26 1990-02-27 Becton, Dickinson And Company Cascade immunoassay by multiple binding reactions
US5017473A (en) 1987-05-26 1991-05-21 Becton, Dickinson And Company Homogeneous chemiluminescence immunoassay using a light absorbing material
CA2000678A1 (en) * 1988-11-17 1990-05-17 John E. Reardon Chromogenic substrate for esterase and immunoassay using same
AU656721B2 (en) 1989-12-29 1995-02-16 Symex Corp. Methods for diagnosting human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrates for use therein
US5314801A (en) 1992-11-06 1994-05-24 Becton, Dickinson And Company Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis
US5470723A (en) 1993-05-05 1995-11-28 Becton, Dickinson And Company Detection of mycobacteria by multiplex nucleic acid amplification
US5457027A (en) 1993-05-05 1995-10-10 Becton, Dickinson And Company Internal controls for isothermal nucleic acid amplification reactions
US5518884A (en) 1994-02-28 1996-05-21 Becton, Dickinson And Company Nucleic acid sequences specific for mycbacterium kansasii
US5639428A (en) 1994-07-19 1997-06-17 Becton Dickinson And Company Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US6194220B1 (en) 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
NZ335368A (en) 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
AU1927899A (en) * 1997-12-18 1999-07-05 Sepracor, Inc. Screening assays for the detection and diagnosis of influenza virus
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
JP2002541858A (ja) 1999-04-16 2002-12-10 ザイメテックス インコーポレイテッド ウイルス由来の酵素および化学発光基質を用いるウイルス検出法
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
EP1253203A1 (en) 2001-04-25 2002-10-30 Becton Dickinson and Company Rapid resuscitation, growth, capture and detection of microorganisms
CA2523016C (en) 2003-04-25 2018-05-15 Becton, Dickinson And Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
US7595152B2 (en) 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
WO2007053487A2 (en) * 2005-10-28 2007-05-10 Binax, Inc. Methods and devices for detection of the strain of a pathogen
US8163237B2 (en) 2006-05-08 2012-04-24 Becton, Dickinson And Company Vascular access device pathogenic status indication
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
MX2008014529A (es) 2006-05-18 2009-01-28 Veterinaermedizinische Uni Wie Metodo de deteccion para virus de influenza.
JP2008014751A (ja) 2006-07-05 2008-01-24 Denka Seiken Co Ltd 着色ラテックス粒子を用いるメンブレンアッセイ法およびキット
JP5300200B2 (ja) 2006-08-31 2013-09-25 大阪府 トリインフルエンザウイルスに特異的な迅速診断法
US9086408B2 (en) * 2007-04-30 2015-07-21 Nexus Dx, Inc. Multianalyte assay
US7893272B2 (en) 2007-05-15 2011-02-22 Cellex, Inc. Reagents and kits for detection of influenza virus and the like
US8163474B2 (en) * 2008-03-15 2012-04-24 Arbor Vita Corporation NS1-NP diagnostics of influenza virus infection
CA2761733C (en) * 2009-06-01 2019-01-08 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Reagents and methods for detecting influenza virus proteins
WO2014165536A1 (en) 2013-04-01 2014-10-09 Becton, Dickinson And Company Methods and kits for the diagnosis of influenza

Also Published As

Publication number Publication date
KR102348484B1 (ko) 2022-01-07
CN108663518A (zh) 2018-10-16
RU2713112C2 (ru) 2020-02-03
WO2014165536A1 (en) 2014-10-09
CA2908028A1 (en) 2014-10-09
US20190339272A1 (en) 2019-11-07
AU2020227005A1 (en) 2020-09-17
KR20160018479A (ko) 2016-02-17
US20160041167A1 (en) 2016-02-11
CN105264086A (zh) 2016-01-20
CN108663518B (zh) 2022-03-11
BR112015025042B1 (pt) 2023-11-14
RU2015141509A3 (https=) 2018-03-30
ES2754402T3 (es) 2020-04-17
AU2020227005B2 (en) 2022-12-08
AU2014248225A1 (en) 2015-10-29
WO2014165536A8 (en) 2016-09-01
BR112015025042A2 (https=) 2017-09-05
US10317404B2 (en) 2019-06-11
US11209433B2 (en) 2021-12-28
JP2019215377A (ja) 2019-12-19
JP6591398B2 (ja) 2019-10-16
EP2981618B1 (en) 2019-08-28
EP2981618A1 (en) 2016-02-10
CN105264086B (zh) 2018-06-15
RU2015141509A (ru) 2017-05-16
AU2014248225B2 (en) 2020-06-25
JP7096219B2 (ja) 2022-07-05
US12372525B2 (en) 2025-07-29
US20220146514A1 (en) 2022-05-12
JP2016524127A (ja) 2016-08-12

Similar Documents

Publication Publication Date Title
US12372525B2 (en) Methods and kits for the diagnosis of influenza
CN109580958B (zh) 一种心肌肌钙蛋白i的荧光和比色双信号检测试剂盒及检测方法
Richter et al. Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors
US20090111091A1 (en) Specimen pretreatment liquid, kit for measuring virus, and method for detecting virus
Tabata et al. Antibody-free digital influenza virus counting based on neuraminidase activity
Verma et al. Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report
Chabi et al. Smartphone-read phage lateral flow assay for point-of-care detection of infection
CN111273017A (zh) 一种快速检测新型冠状病毒的荧光免疫层析试剂盒
Zhao et al. Progress of the Detection Methods for SARS-CoV-2.
Forghani Diagnosis by viral antigen detection
McHenry et al. Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry
Hasan et al. A novel real-time PCR assay panel for detection of common respiratory pathogens in a convenient, strip-tube array format
CN103123356B (zh) 一种时间分辨荧光法综合检测子宫癌试剂盒及其应用
US12366581B2 (en) Methods, compositions, and systems for detecting coronavirus neutralizing antibodies
WO2022136576A1 (en) Liposome-receptor-assay for detecting neutralizing antibodies
Lin et al. A biochemiluminescent assay for rapid diagnosis of influenza
Bhatia et al. Study of Various Diagnostic Tests for COVID-19: A Review
Das Design and development of small molecule based biosensors for detection of pathogens
Gheyath K et al. Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
Baron Multiple test methods for the detection of novel H1N1
EP2032988B1 (en) Multiple labelling for analyte detection

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190326

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250320

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251010

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260319

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260319